284 related articles for article (PubMed ID: 34048614)
21. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.
Cyrenne BM; Al-Mohammedi F; DeKoven JG; Alhusayen R
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e546-e548. PubMed ID: 33982814
[No Abstract] [Full Text] [Related]
22. Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID-19 vaccines: A report of two cases.
Bostan E; Elmas L; Yel B; Yalici-Armagan B
Dermatol Ther; 2021 Nov; 34(6):e15110. PubMed ID: 34427024
[No Abstract] [Full Text] [Related]
23. Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis.
Ducloux D; Colladant M; Chabannes M; Yannaraki M; Courivaud C
Kidney Int; 2021 Sep; 100(3):702-704. PubMed ID: 34216675
[No Abstract] [Full Text] [Related]
24. Viral-like Reaction or Hypersensitivity? Erythema Multiforme Minor Reaction and Moderate Eosinophilia After the Pfizer-BioNTech BNT162b2 (mRNA-Based) SARS-CoV-2 Vaccine.
de Las Vecillas L; López J; Morchón E; Rodriguez F; Drake M; Martino M
J Investig Allergol Clin Immunol; 2021 Feb; 32(1):77-78. PubMed ID: 34588156
[No Abstract] [Full Text] [Related]
25. Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine.
Okan G; Vural P
Dermatol Ther; 2022 Mar; 35(3):e15280. PubMed ID: 34931408
[No Abstract] [Full Text] [Related]
26. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
Matsumura A; Katsuki K; Akimoto M; Sakuma T; Nakajima Y; Miyazaki T; Fujisawa S; Nakajima H
Rinsho Ketsueki; 2021; 62(11):1639-1642. PubMed ID: 34866090
[TBL] [Abstract][Full Text] [Related]
27. Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older.
Auster O; Finkel U; Dagan N; Barda N; Laufer A; Balicer RD; Ben-Shachar S
JAMA Netw Open; 2022 Apr; 5(4):e227657. PubMed ID: 35435973
[TBL] [Abstract][Full Text] [Related]
28. Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up: comment.
Serraino C; Melchio R; Badinella Martini M; Gerbaudo L; Fenoglio L
Intern Emerg Med; 2022 Jan; 17(1):311-312. PubMed ID: 35006536
[No Abstract] [Full Text] [Related]
29. Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.
Haller MC; Kaiser RA; Langthaler S; Brandstetter C; Apfalter P; Kerschner H; Cejka D
Transpl Int; 2021; 35():10026. PubMed ID: 35185359
[No Abstract] [Full Text] [Related]
30. Demographic and Clinical Factors Associated With Anti-SARS-CoV-2 Antibody Levels After 2 BNT162b2 mRNA Vaccine Doses.
Nam SY; Jeon SW; Lee HS; Lim HJ; Lee DW; Yoo SS
JAMA Netw Open; 2022 May; 5(5):e2212996. PubMed ID: 35587345
[TBL] [Abstract][Full Text] [Related]
31. Non-episodic angioedema with eosinophilia after BNT162b2 mRNA COVID-19 vaccination.
Ishizuka K; Katayama K; Kaji Y; Tawara J; Ohira Y
QJM; 2021 Dec; 114(10):745-746. PubMed ID: 34546346
[No Abstract] [Full Text] [Related]
32. Boosting maternal and neonatal humoral immunity following SARS-CoV-2 infection using a single messenger RNA vaccine dose.
Nevo L; Cahen-Peretz A; Vorontsov O; Frenkel R; Kabessa M; Cohen SM; Hamrani A; Oiknine-Djian E; Lipschuetz M; Goldman-Wohl D; Walfisch A; Kovo M; Neeman M; Yagel S; Wolf DG; Beharier O
Am J Obstet Gynecol; 2022 Sep; 227(3):486.e1-486.e10. PubMed ID: 35430228
[TBL] [Abstract][Full Text] [Related]
33. Kounis syndrome associated with BNT162b2 mRNA COVID-19 vaccine presenting as ST-elevation acute myocardial infarction.
Şancı E; Örçen C; Çelik OM; Özen MT; Bozyel S
Anatol J Cardiol; 2022 Jan; 26(1):69-74. PubMed ID: 35191390
[No Abstract] [Full Text] [Related]
34. Comparison of antibody response to two different mRNA Covid-19 vaccines in patients on hemodialysis.
Ionita C; Marcelli D; Nita C; Anton C; Berca S; Vacar S; Schiller O; Gheorghiu C; Barth C
J Nephrol; 2022 Jan; 35(1):143-151. PubMed ID: 34978050
[TBL] [Abstract][Full Text] [Related]
35. Humoral and Cellular Immunogenicity of the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Nursing Home Residents.
Van Praet JT; Vandecasteele S; De Roo A; De Vriese AS; Reynders M
Clin Infect Dis; 2021 Dec; 73(11):2145-2147. PubMed ID: 33825869
[No Abstract] [Full Text] [Related]
36. Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up-Reply.
Ferrara P; Antonazzo IC; Polosa R
Intern Emerg Med; 2022 Jan; 17(1):313-314. PubMed ID: 35006537
[No Abstract] [Full Text] [Related]
37. Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case series.
Koumaki D; Krueger-Krasagakis SE; Papadakis M; Katoulis A; Koumaki V; Evangelou G; Stefanidou M; Mylonakis D; Zografaki K; Krasagakis K
J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e85-e86. PubMed ID: 34606142
[No Abstract] [Full Text] [Related]
38. Impact of prior infection status on antibody response to the BNT162b2 mRNA COVID-19 vaccine in healthcare workers at a COVID-19 referral hospital in Milan, Italy.
Milazzo L; Pezzati L; Oreni L; Kullmann C; Lai A; Gabrieli A; Bestetti G; Beschi C; Conti F; Ottomano C; Gervasoni C; Meroni L; Galli M; Antinori S; Ridolfo AL
Hum Vaccin Immunother; 2021 Dec; 17(12):4747-4754. PubMed ID: 35086438
[TBL] [Abstract][Full Text] [Related]
39. Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.
Jalkanen P; Kolehmainen P; Haveri A; Huttunen M; Laine L; Österlund P; Tähtinen PA; Ivaska L; Maljanen S; Reinholm A; Belik M; Smura T; Häkkinen HK; Ortamo E; Kantele A; Julkunen I; Lempainen J; Kakkola L
Microbiol Spectr; 2022 Apr; 10(2):e0225221. PubMed ID: 35262410
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the QuantiFERON SARS-CoV-2 assay to assess cellular immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in individuals with low and high humoral response.
Tychala A; Meletis G; Katsimpourlia E; Gkeka I; Dimitriadou R; Sidiropoulou E; Skoura L
Hum Vaccin Immunother; 2021 Dec; 17(12):5148-5149. PubMed ID: 34714711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]